ORIC Pharmaceuticals
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- ORIC Pharmaceuticals
- Company name
- ORIC Pharmaceuticals
- Organisation type
- Industry
- Registered legal name
- ORIC PHARMACEUTICALS, INC.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001796280
- Legal Entity Identifier (LEI)
- 54930033FJRNEYBW0L25
Related records
Trials (10)
- A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Effect of Food on the Pharmacokinetics of ORIC-114
- ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
- Single and Multiple Dose Study of ORIC-101 in Adult Healthy Subjects
- Study of ORIC-101 in Combination With Anticancer Therapy
- Study of ORIC-101 in Combination With Enzalutamide
- Study of ORIC-101 in Healthy Adult Subjects
- Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma
- Study of ORIC-944 in Patients With Metastatic Prostate Cancer